Hepatitis C virus NS3/4A inhibitors and other drug-like compounds as covalent binders of SARS-CoV-2 main protease

Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), threatens global public health. The world needs rapid development of new antivirals and vaccines to control the current pandemic and to control the spread of the variants. Among the protei...

Descripción completa

Detalles Bibliográficos
Autores principales: Andi, Babak, Kumaran, Desigan, Kreitler, Dale F., Soares, Alexei S., Keereetaweep, Jantana, Jakoncic, Jean, Lazo, Edwin O., Shi, Wuxian, Fuchs, Martin R., Sweet, Robert M., Shanklin, John, Adams, Paul D., Schmidt, Jurgen G., Head, Martha S., McSweeney, Sean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287821/
https://www.ncbi.nlm.nih.gov/pubmed/35842458
http://dx.doi.org/10.1038/s41598-022-15930-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287821/
https://www.ncbi.nlm.nih.gov/pubmed/35842458
http://dx.doi.org/10.1038/s41598-022-15930-z

Ejemplares similares